ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 168 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $72 | -20.9% | 14,702 | +0.5% | 0.00% | – |
Q4 2022 | $91 | -99.9% | 14,625 | +3.8% | 0.00% | -100.0% |
Q3 2022 | $151,000 | +3.4% | 14,083 | +9.7% | 0.00% | 0.0% |
Q2 2022 | $146,000 | -60.4% | 12,835 | -68.4% | 0.00% | -50.0% |
Q1 2022 | $369,000 | -24.1% | 40,589 | +24.3% | 0.00% | 0.0% |
Q4 2021 | $486,000 | +89.1% | 32,646 | +226.5% | 0.00% | +100.0% |
Q3 2021 | $257,000 | +233.8% | 10,000 | +227.4% | 0.00% | 0.0% |
Q4 2020 | $77,000 | – | 3,054 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
Navalign, LLC | 64,428 | $961,000 | 0.38% |
Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |